Compare Repligen Corporation Common Stock (RGEN) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Waste Management, Inc. — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Waste Management, Inc. trades at $218.93 (market cap $84.67B). The key difference: Waste Management, Inc. is far larger — about 7.6× Repligen Corporation Common Stock's market cap, and Waste Management, Inc. pays a 1.78% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Waste Management, Inc. for 131 Days on average.
| RGEN | WM | |
|---|---|---|
Market Cap | $11.14B | $84.67B |
Volume | 1,259,263 | 1,534,456 |
Sector | Health | Industrials |
52-Week High | $194.57 | $246.51 |
52-Week Low | $102.87 | $196.77 |
Typical Hold Time | 0 Days | 131 Days |
Enterprise Value | $11.02B | $107.47B |
Dividend Yield | — | 1.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
WM trades at $215.75, up 2.18% today, with a bullish technical signal despite mixed momentum indicators. The company reported strong revenue growth to $25.20 billion in 2025 and beat earnings estimates in two of the last three quarters. Analyst consensus is positive with 54% buy ratings, and the stock offers a dividend yield supported by robust cash flow from operations of $6.04 billion.
Outlook remains favorable due to pricing power and acquisition strategy, but elevated debt levels and a high P/E ratio of 29.96 pose risks. Near-term performance hinges on Q3 2026 earnings results expected on October 27, 2026, with investor focus on margin sustainability and debt management amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
